Therapeutic targets for enterovirus infections

Area of Science:

• Virology
• Drug Discovery

Background:

• Enteroviruses cause widespread acute and chronic infections, incurring substantial economic costs.
• There is a critical need for novel, non-toxic antiviral agents to reduce enterovirus load in individuals and on surfaces.

Purpose of the Study:

• To review recent findings on compounds and tools targeting enteroviruses and host cell molecules.
• To outline modern methods for identifying new targets and understanding antiviral mechanisms of action.

Main Methods:

• High-throughput molecular screening to identify potential antiviral targets and compounds.
• Review of existing literature on enterovirus research and antiviral development.
• Discussion of advanced molecular tools like cryo-electron microscopy (cryo-EM), docking, and simulation.

Main Results:

• High-throughput screens have elucidated key aspects of the enterovirus life cycle and identified potential antiviral targets.
• Direct capsid binders may face resistance issues, but combination therapies targeting conserved processes show future therapeutic potential.
• Advanced computational and structural tools are crucial for understanding antiviral mechanisms.

Conclusions:

• Developing effective antivirals against enteroviruses requires a multifaceted approach, including novel drug discovery and understanding resistance mechanisms.
• Combination therapies and advanced molecular tools are essential for future enterovirus treatment strategies.
• Further research utilizing cryo-EM, docking, and simulation will enhance the development of next-generation antivirals.